Quinolines that modulate SERCA and their use for treating disease
US10772881B2 · kind B2 · utility
5Cited by
0References
8Claims
0Family size
Inventor
Key dates
| Filing date | Jan 25, 2019 |
| Grant date | Sep 15, 2020 |
| Priority date | — |
| Expiry date | Jan 25, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are quinolines, e.g., a compound of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes. Also provided herein are methods of their use for modulating the activity of a sarcoplasmic/endoplasmic reticulum C2+ ATPase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.